Anhui Fengyuan Pharmaceutical Co Ltd Financial Flexibility Index
Anhui Fengyuan Pharmaceutical Co Ltd financial flexibility index. Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥101.17 Million (operating CF CN¥69.15 Million minus capex CN¥32.02 Million) represents 0% of total liabilities (CN¥2.84 Billion). Explore Anhui Fengyuan Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Financial flexibility index of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. Historical Financial Flexibility Index trend for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. Check 000153 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Anhui Fengyuan Pharmaceutical Co Ltd Financial Flexibility Index by Year (1999–2025)
Anhui Fengyuan Pharmaceutical Co Ltd financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Anhui Fengyuan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Anhui Fengyuan Pharmaceutical Co Ltd (000153) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥339.90 Million | CN¥119.30 Million | CN¥2.93 Billion | ▲ +13.7% |
| 2024 | 0.10x | CN¥270.25 Million | CN¥126.24 Million | CN¥2.65 Billion | ▼ -38.1% |
| 2023 | 0.16x | CN¥406.87 Million | CN¥254.75 Million | CN¥2.47 Billion | ▼ -14.4% |
| 2022 | 0.19x | CN¥521.75 Million | CN¥439.99 Million | CN¥2.71 Billion | ▲ +9.8% |
| 2021 | 0.17x | CN¥395.24 Million | CN¥237.88 Million | CN¥2.26 Billion | ▼ -20.8% |
| 2020 | 0.22x | CN¥483.50 Million | CN¥292.75 Million | CN¥2.19 Billion | ▲ +132.9% |
| 2019 | 0.09x | CN¥211.83 Million | CN¥66.21 Million | CN¥2.23 Billion | ▼ -48.8% |
| 2018 | 0.19x | CN¥318.23 Million | CN¥233.59 Million | CN¥1.72 Billion | ▲ +185.8% |
| 2017 | 0.06x | CN¥100.38 Million | CN¥52.40 Million | CN¥1.55 Billion | ▼ -13.5% |
| 2016 | 0.08x | CN¥100.38 Million | CN¥78.21 Million | CN¥1.34 Billion | ▼ -12.2% |
| 2015 | 0.09x | CN¥95.83 Million | CN¥45.50 Million | CN¥1.12 Billion | ▼ -50.0% |
| 2014 | 0.17x | CN¥186.37 Million | CN¥10.51 Million | CN¥1.09 Billion | ▲ +263.3% |
| 2013 | 0.05x | CN¥43.59 Million | CN¥-70.31 Million | CN¥926.72 Million | ▼ -77.4% |
| 2012 | 0.21x | CN¥140.71 Million | CN¥45.65 Million | CN¥675.47 Million | ▼ -7.8% |
| 2011 | 0.23x | CN¥124.92 Million | CN¥55.06 Million | CN¥552.99 Million | ▼ -18.6% |
| 2010 | 0.28x | CN¥144.79 Million | CN¥55.04 Million | CN¥522.02 Million | ▲ +36.8% |
| 2009 | 0.20x | CN¥106.82 Million | CN¥32.41 Million | CN¥526.78 Million | ▲ +27.4% |
| 2008 | 0.16x | CN¥81.41 Million | CN¥49.82 Million | CN¥511.47 Million | ▼ -20.8% |
| 2007 | 0.20x | CN¥90.44 Million | CN¥55.26 Million | CN¥449.73 Million | ▼ -48.2% |
| 2006 | 0.39x | CN¥172.94 Million | CN¥36.27 Million | CN¥445.10 Million | ▲ +171.5% |
| 2005 | 0.14x | CN¥70.55 Million | CN¥34.88 Million | CN¥493.08 Million | ▲ +23.7% |
| 2004 | 0.12x | CN¥35.27 Million | CN¥-11.72 Million | CN¥304.86 Million | ▼ -58.8% |
| 2003 | 0.28x | CN¥45.18 Million | CN¥-11.46 Million | CN¥160.93 Million | ▼ -66.0% |
| 2002 | 0.82x | CN¥101.88 Million | CN¥10.48 Million | CN¥123.55 Million | ▼ -33.1% |
| 2001 | 1.23x | CN¥213.80 Million | CN¥23.57 Million | CN¥173.33 Million | ▼ -12.2% |
| 2000 | 1.40x | CN¥143.70 Million | CN¥25.88 Million | CN¥102.28 Million | ▲ +1948.2% |
| 1999 | 0.07x | CN¥5.60 Million | CN¥1.01 Million | CN¥81.65 Million | — |